Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-771

5 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 63323-771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azaci-struc-01.jpg (Azaci Struc 01)

Azaci-struc-01.jpg (Azaci Struc 01)
Chemical structure diagram of Azacitidine showing its molecular configuration with labeled atoms and bonds. The structure highlights key features such as amino and hydroxyl groups, reflecting its identity as the active ingredient in the Azacitidine injection, powder, lyophilized, for solution product.*
FDA Label Image

Azaci-img-01.jpg (Azaci Img 01)

Azaci-img-01.jpg (Azaci Img 01)
A Kaplan-Meier survival curve comparing proportional survival over time in months from randomization between two groups labeled AZA and CCR. The graph includes the number of subjects at risk over time and statistical values such as Log-Rank p-value and hazard ratio (HR).*
FDA Label Image

Azaci-img-02.jpg (Azaci Img 02)

Azaci-img-02.jpg (Azaci Img 02)
Azacitidine 100 mg/30 mL lyophilized powder for injection vial label from Fresenius Kabi USA, LLC. The label shows the product name and strength, and indicates it is for intravenous and subcutaneous use. The packaging is primarily white with black text and the Fresenius Kabi logo on the vial.*
FDA Label Image

Azaci-label-01.jpg (Azaci Label 01)

Azaci-label-01.jpg (Azaci Label 01)
Label for Azacitidine for Injection 100 mg/vial, a lyophilized powder for solution by Fresenius Kabi USA, LLC. The label indicates the product is for subcutaneous and intravenous use only, single-dose vial, containing azacitidine 100 mg and mannitol 100 mg. Storage instructions specify 25°C (77°F) with permitted excursions. Manufactured in India.*
FDA Label Image

Azaci-label-02.jpg (Azaci Label 02)

Azaci-label-02.jpg (Azaci Label 02)
Packaging label for Azacitidine for Injection 100 mg/vial, a lyophilized powder for injection intended for subcutaneous and intravenous use. The label includes dosage strength, NDC 63323-771-39, manufacturer Fresenius Kabi USA, LLC, and storage instructions. The package contains one single-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.